Interestingly, the effect of NPY on NB cell invasiveness exhibited a linear dose dependence, suggesting the involvement of additional, potentially RhoA-independent mechanisms in interactions with extracellular matrix and its degradation. The gene discussed is RHOA; the disease is neuroblastoma.